Halomine, Inc dba AvantGuard, Inc.

Halomine is developing the next generation of bio-inspired, non-resistant treatments for bacteria and fungi.

  • Stage Prototype Ready
  • Industry Chemicals and Chemical Products
  • Location Ithaca, NY, USA
  • Currency USD
  • Founded June 2018
  • Employees 17
  • Incorporation Type C-corp
  • Website com

Company Summary

AvantGuard is a Cornell University spin-off/IndieBio alum with $8 million in grant funding from the NIH, NSF and $4 million in equity. We improve upon our own immune system to create a proprietary topical treatment against bacteria and fungi that performs better than antibiotics, with no risk of resistance generation, opening up a $10 billion topical treatment market.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free